Researchers at the Center for Nanoparticle Research, within the Institute for Basic Science (IBS, South K...
RaySearch Laboratories AB (publ) names Yonsei Cancer Center in Seoul, South Korea, as the first clinic in the ...
A new study, published in Lancet Digital Health, shows the added value of AI-aided breast cancer detection from mammogra...
Korea Centers for Disease Control & Prevention notified Seegene Inc. that Korea Ministry of Food and Drug Safety has...
South Korea based Bukwang Pharmaceuticals recently announced that the US Food and Drug Administration (FDA) has approved...
Hough Ear Institute (HEI), a nonprofit based in Oklahoma City, US is proud to announce that its pharmaceutical part...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea has acquired ...
Asia-Pacific specialist CRO Novotech has won the Australian-Korean Business Awards 2020 - Award for Excellence, in ...
South Korea based Samsung Biologics, a pharmaceutical Contract Manufacturing Organization (CMO), recorded high for the f...
UK based Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that ...
Belgium based PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active imm...
US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repai...
US based Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-bas...
KT Corporation, Korea's largest telecommunications company, and the Samsung Medical Center (SMC) announced last week tha...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced th...
The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Mo...
Diabetic patients need to measure their blood-sugar level by drawing blood before and after a meal and it is easy to dev...
A2A Pharmaceuticals Inc. (A2A) announced an agreement to design and co-develop oncology drug candidates with Daewoong Ph...
